Partial deletion of chromosome 2 syndrome

Partial deletion of chromosome 2 syndrome (also referred to as partial monosomy 2 or 2p/2q partial deletion syndrome, Orphanet code 261771) encompasses a group of rare chromosomal disorders caused by the loss of a segment of chromosome 2. Because chromosome 2 is one of the largest human chromosomes, the clinical presentation varies considerably depending on the size and precise location of the deleted segment (whether on the short arm 2p or the long arm 2q). This condition is typically identified prenatally or in early infancy due to the presence of congenital anomalies. Affected individuals commonly present with intellectual disability of variable severity, developmental delay (motor and speech), growth retardation, and distinctive craniofacial dysmorphic features. Craniofacial findings may include microcephaly, a broad or flat nasal bridge, low-set or malformed ears, micrognathia, and hypertelorism. Depending on the specific chromosomal region involved, additional features can include congenital heart defects, skeletal anomalies, genitourinary malformations, hypotonia, seizures, and feeding difficulties in infancy. Some patients may also exhibit behavioral abnormalities or features overlapping with autism spectrum disorder. There is no curative treatment for partial deletion of chromosome 2 syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific clinical manifestations. This may include early intervention programs, speech and occupational therapy, physical therapy, cardiac monitoring or surgical correction of heart defects, antiepileptic medications for seizures, and special educational support. Genetic counseling is recommended for affected families to assess recurrence risk, particularly if a parent carries a balanced chromosomal rearrangement such as a translocation or inversion that predisposes to unbalanced offspring.

Common questions about Partial deletion of chromosome 2 syndrome